Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-25 @ 1:47 AM
NCT ID:
NCT04290494
Eligibility Criteria:
Inclusion Criteria:
* Patient group A: All AIS patients
* Aged 18 80 years
* Diagnosed with AIS on admission
* Patient groups B and B': IVT eligible patients
* Met the in- and exclusion criteria of "all AIS patients"
* Arrived at hospital within 2 h (patient group B) or 3.5 h (patient group B') of symptom onset
* Patient groups C and C': IV rtPA treated patients
* Met the in- and exclusion criteria of "IVT eligible patients"
* Treated with IV rtPA within 3 h (patient group C) or 4.5 h (patient group C') of symptom onset
Exclusion Criteria:
* Patient group A: All AIS patients
* Missing baseline data including age and gender
* Diagnosed with intracranial hemorrhage (ICH), Transient Ischemic Attack (TIA), subarachnoid hemorrhage (SAH), or unspecific stroke
* Arrived at hospital after 7 days of symptom onset
* Patient groups B and B': IVT eligible patients
* Missing key data including:
i. symptom onset time (or last known well time) ii. hospital arrival time iii. whether received IVT treatment or not iv. the time of IVT treatment
* Documented IVT absolute contraindications, according to the case report form (CRF) for each wave of CNSR
* Patient groups C and C': IV rtPA treated patients
* Not received IVT
* Received IVT other than rtPA
* Treated with IV rtPA after 3 h (patient group C) or 4.5 h (patient group C') of symptom onset
* Received additional treatments with intra arterial reperfusion or experimental therapies
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04290494
Study Brief:
Protocol Section:
NCT04290494